Benny pharmaceutical products has been questioned certificates have been asked to recall heparin products

 Benny
pharmaceutical market for the recent (002550) CEP certification and product quality problems to say, was silent for some time to respond formally today, Benny pharmaceutical. Quality Director of the company, Deputy General Manager Fan swimming in an interview that Benny fictional pharmaceutical company in the prospectus certificate of the EU CEP's information, which means that for the EU pharmaceutical market, pharmaceutical companies are not Benny pharmaceutical, it is described in the prospectus of the many facts and advantages not established. In addition, due to quality problems, Benny heparin pharmaceutical products in 2008 by the German government drug regulatory authorities requested the recall, this is also in its prospectus were deliberately concealed.

public information, pharmaceutical Benny for the first time in July 2003 commissioned by the German company to apply for EU HELM COS Certification (Certification of Suitability), the European Quality of Medicines (EDQM) Official issued a certificate of heparin API CEP. Benny then also passed several drug rehabilitation certification, EDQM CEP last issued certificate number as

the above questions, Fan Yong said, production of heparin API products. CEP certification is proof of the most important role of the product manufacturer and product quality in the process system is required to meet EU Pharmacopoeia, whereby Benny pharmaceutical products open the door to European exports, and Europe with a group of internationally renowned pharmaceutical companies such as Sandoz, Austria glass Crane, HELM companies to establish a long-term stable relationships with their customers. drug-related side said that companies and regulators have ruled out the components of the Benny contaminated heparin drug suspect, Benny the corresponding pharmaceutical product quality problems do not exist. Early March 2008, the Wall Street Journal reported: Ge Heer Germany Schleswig-Holstein Ministry of Health issued a document that has been recalled three batches of the heparin active ingredient is used in Changzhou, China lays of the biochemical system Pharmaceutical Co., Ltd. and a company. However, the end of the month, the Wall Street Journal reported again: The recalled heparin products overseas enterprise quality management has been recognized head of the Department of heparin on the composition of the recall were tested to exclude heparin pharmaceutical composition of Benny suspected contamination. And the result has been the official medicines control laboratories in Germany recognized.